Uncategorized
STAAR Surgical Reports First Quarter 2020 Results
LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2020. First Quarter 2020 Overview Net Sales of $35.2 Million Up 8% from the Prior Year Quarter ICL Sales of $29.3 Million Up 6% and Units Up 9% from the Prior Year Quarter Gross Margin at 70.4% vs. 74.2% in the Prior Year Quarter Net Loss